Elfin Agro India Share Price & Earnings Call Analysis
- Market cap
- ₹169 Cr
- P/E
- 29.29
- ROE
- 20.13%
- PEG
- 0.63
- Price to sales
- 0.96
- Debt to equity
- 0.10
- EBITDA margin
- 5.21%
- Net profit margin
- 3.29%
- Promoter holding
- 72.59%
- Sales (last year)
- ₹175 Cr
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Food Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹23,562 Cr | 134.3 | |
| 2 | 40%+ | Up 2%+ | ₹435 Cr | 7.5 | |
| 3 | 40%+ | Up 2%+ | ₹413 Cr | 72.6 | |
| 4 | 40%+ | Flat | ₹1,012 Cr | 46.0 | |
| 5 | 40%+ | Flat | ₹148 Cr | 9.8 | |
| 6 | 20–40% | Up 2%+ | ₹670 Cr | 48.3 |
Sign up free to see every company in the sector ranking and track Elfin Agro India.
Pro shows every company guiding 40%+ revenue growth →Full Food Products rankingFinancials of Elfin Agro India
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Elfin Agro India
Quarterly Results
Quarter-by-quarter operating performance
| Sales + |
| Expenses + |
| Operating Profit |
| OPM % |
| Other Income + |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit + |
| EPS in Rs |
Financials of Elfin Agro India
Profit & Loss
Annual income statement trend
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Sales + | 100 | 123 | 145 |
| Expenses + | 97 | 118 | 137 |
| Operating Profit | 3 | 6 | 8 |
| OPM % | 3% | 5% | 5% |
| Other Income + | 0 | 0 | 1 |
| Interest | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 3 | 5 | 7 |
| Tax % | 30% | 26% | 25% |
| Net Profit + | 2 | 4 | 5 |
| EPS in Rs | 12.84 | 26.10 | 3.60 |
| Dividend Payout % | 0% | 0% | 0% |
Financials of Elfin Agro India
Balance Sheet
Capital structure and asset base
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 1 | 1 | 7 |
| Reserves | 4 | 7 | 7 |
| Borrowings + | 7 | 8 | 12 |
| Other Liabilities + | 9 | 8 | 7 |
| Total Liabilities | 21 | 25 | 33 |
| Fixed Assets + | 8 | 10 | 10 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets + | 13 | 14 | 23 |
| Total Assets | 21 | 25 | 33 |
Financials of Elfin Agro India
Cash Flows
Operating, investing and financing cash movement
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Cash from Operating Activity + | 0 | 3 | -3 |
| Cash from Investing Activity + | -3 | -2 | -0 |
| Cash from Financing Activity + | 3 | -0 | 4 |
| Net Cash Flow | -0 | 0 | 0 |
| Free Cash Flow | -3 | -0 | -4 |
| CFO/OP | 19% | 62% | -16% |
Financials of Elfin Agro India
Ratios
Working capital efficiency and return ratios
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 19 | 18 | 23 |
| Inventory Days | 24 | 22 | 31 |
| Days Payable | 30 | 21 | 14 |
| Cash Conversion Cycle | 13 | 19 | 40 |
| Working Capital Days | 3 | 0 | 12 |
| ROCE % | 40% | 36% |
Continue your research
Others in Food Products this season
- Zydus Wellness (Q2 FY27)
Net Sales for Q2 FY27: INR 11,227 million, up 74.6% YoY from INR 6,429 million in Q2 FY26. Key investor presentation takeaways from Zydus Wellness Ltd's Q2 FY27
- Hoac Foods (Q2 FY27)
Revenue from operations (gross) for the quarter ended September 30, 2026, is ₹2,326.15 lakh (Standalone) and ₹2,314.04 lakh (Consolidated). Key results statemen
- Narmada Agrobase (Q2 FY27)
EBITDA for the quarter ended September 30, 2026: ₹2303.54 lakhs, up from ₹2153.41 lakhs in the same quarter last year (YoY increase). Key results statement take
- Dangee Dums (Q2 FY27)
700.42 lakhs for the quarter ended September 30, 2025, reflecting a year-on-year increase of approximately 13.37%. Key results statement takeaways from Dangee D